Repeated CT scans on 12,984 Asians to diagnose lung cancer once it is suspected.
Journal
Frontiers in oncology
Journal Volume
14
ISSN
2234-943X
Date Issued
2024
Author(s)
Vy, Vu Pham Thao
Chien, Li-Nien
Chen, Wan-Ting
Lin, Wan-Ying
Hsu, Hsian-He
Chan, Wing P
DOI
10.3389/fonc.2024.1394402
Abstract
In Taiwan, lung cancer remains the leading cause of cancer-related fatalities, resulting in substantial healthcare expenses. This research aims to evaluate both the frequency and the costs of low-dose computed tomography (LDCT) in individuals suspected of having lung cancer until their diagnosis of cancer. LDCT screening was not conducted on a population-wide scale, and asymptomatic participants had to cover the expenses for the screening personally or reimburse from other sources. If the screening results were positive or suspicious, National Health Insurance (NHI) could be utilized for subsequent follow-up examinations. This cohort study utilized the NHI Database and focused on individuals with suspected cases of lung cancer identified between 2010 and 2014. A total of 17,572 suspected new lung cancer cases were initially identified and assigned to the relevant International Classification of Diseases codes. Individuals with suspected lung cancer received a diagnosis following an average follow-up period of 2.24 (95%CI, 2.11-2.37) years, and required the use of 2.36 (95%CI, 2.20-2.51) repeated CT scans. The NHI expenditures incurred by the use of CT scans for monitoring suspected lung cancer cases were relatively modest.
Subjects
Asian
cancer screening
computed tomography (CT) scan
cost
lung cancer
SDGs
Publisher
Frontiers Media SA
Description
Article number 1394402
Type
journal article